Both in Pharmaceuticals
Nkarta vs Foghorn Therapeutics
Over the past year NKTX returned −25.5% and FHTX returned −52.1%; their daily moves had a correlation of 0.34.
NKTX −25.5% FHTX −52.1%Growth of $1, one year, split-adjusted
| Metric | NKTX | FHTX |
|---|---|---|
| Price | $1.72 | $2.13 |
| Market cap | $123.2M | $126.5M |
| Today | +1.18% | +3.90% |
| 1 month | −34.4% | −39.5% |
| 6 months | −36.1% | −55.3% |
| Year to date | −7.0% | −60.6% |
| 1 year | −26.8% | −48.3% |
| Revenue growth (YoY) | — | +112.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | $182.8M | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.8% | 105.8% |
| Short % of float | 8.1% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).